Mena-Vázquez, N.; Rojas-Gimenez, M.; Jimenez Nuñez, F.G.; Manrique-Arija, S.; Rioja, J.; Ruiz-Limón, P.; Ureña, I.; Castro-Cabezas, M.; Valdivielso, P.; Fernández-Nebro, A.
Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis. J. Clin. Med. 2020, 9, 2483.
https://doi.org/10.3390/jcm9082483
AMA Style
Mena-Vázquez N, Rojas-Gimenez M, Jimenez Nuñez FG, Manrique-Arija S, Rioja J, Ruiz-Limón P, Ureña I, Castro-Cabezas M, Valdivielso P, Fernández-Nebro A.
Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis. Journal of Clinical Medicine. 2020; 9(8):2483.
https://doi.org/10.3390/jcm9082483
Chicago/Turabian Style
Mena-Vázquez, Natalia, Marta Rojas-Gimenez, Francisco Gabriel Jimenez Nuñez, Sara Manrique-Arija, José Rioja, Patricia Ruiz-Limón, Inmaculada Ureña, Manuel Castro-Cabezas, Pedro Valdivielso, and Antonio Fernández-Nebro.
2020. "Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis" Journal of Clinical Medicine 9, no. 8: 2483.
https://doi.org/10.3390/jcm9082483
APA Style
Mena-Vázquez, N., Rojas-Gimenez, M., Jimenez Nuñez, F. G., Manrique-Arija, S., Rioja, J., Ruiz-Limón, P., Ureña, I., Castro-Cabezas, M., Valdivielso, P., & Fernández-Nebro, A.
(2020). Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis. Journal of Clinical Medicine, 9(8), 2483.
https://doi.org/10.3390/jcm9082483